✦ LIBER ✦

A review of treatment with mepolizumab, an anti–IL-5 mAb, in hypereosinophilic syndromes and asthma

✍ Scribed by Busse, William W.; Ring, Johannes; Huss-Marp, Johannes; Kahn, Jean-Emmanuel

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

628 Corticosteroid-Sparing Effects of Me

✍ Rosenwasser, L.J.; Schwartz, L.B.; Sheikh, J.; Klion, A.D.; Rothenberg, M.E. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 50 KB

821 Effects of Mepolizumab, an Anti-Inte

✍ Weller, P.F.; Gleich, G.J.; Busse, W.W.; Rothenberg, M.E. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Efficacy and safety of an anti–IL-13 mAb

✍ De Boever, Erika H.; Ashman, Claire; Cahn, Anthony P.; Locantore, Nicholas W.; O 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 705 KB

Rebound eosinophilia after treatment of

✍ Kim, Yae-Jean; Prussin, Calman; Martin, Brian; Law, Melissa A.; Haverty, Thomas 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 217 KB

Rationale and design of a placebo-contro

📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Effect of intravenous administration of

✍ Flood-Page, P.; Phipps, S.; Menzies-Gow, A.; Ong, Y.; Kay, A.B. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 133 KB